CD36 and metabolic dysfunction-associated steatotic liver disease: Two studies observed a decrease in the translation and protein expression of the main lipid uptake transporter Cluster-of-differentiation-36 (CD36)/ Fatty-Acid-translocase (FAT) following exercise of the NAFLD models (Carbajo-Pescador et al., 2019[21]; Linden et al., 2016[89]).